Weekend‐free scheduled IVF/ICSI procedures and single embryo transfer do not reduce live‐birth rates in a general infertile population

Scheduling of ovum pickup only on weekdays may result in cases of apparently suboptimal timing for human chorionic gonadotropin and ovum pickup. This study aimed to assess whether live‐birth rates were reduced in women with a potentially suboptimal day for human chorionic gonadotropin and ovum pickup to avoid weekend work, according to ultrasonographic data on the day of human chorionic gonadotropin planning.

[1]  C. Farquhar,et al.  Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. , 2017, The Cochrane database of systematic reviews.

[2]  G D Adamson,et al.  International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2008, 2009 and 2010. , 2016, Human reproduction.

[3]  M. Eijkemans,et al.  Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial. , 2013, Human reproduction.

[4]  C. Venetis,et al.  Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. , 2013, Human reproduction update.

[5]  A. Balen,et al.  Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial , 2012, Human fertility.

[6]  E. Kolibianakis,et al.  Can oestradiol pretreatment be used to reliably avoid weekend oocyte retrievals? , 2012, Reproductive biomedicine online.

[7]  P. Haentjens,et al.  Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. , 2012, Reproductive biomedicine online.

[8]  H. Tournaye,et al.  Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial. , 2011, Fertility and sterility.

[9]  B. Mol,et al.  Timing oocyte collection in GnRH agonists down-regulated IVF and ICSI cycles: a randomized clinical trial. , 2011, Human reproduction.

[10]  C. Venetis,et al.  Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis. , 2010, Fertility and sterility.

[11]  M. Lane,et al.  Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes. , 2010, Human reproduction.

[12]  A. Revelli,et al.  Construction of an evidence-based integrated morphology cleavage embryo score for implantation potential of embryos scored and transferred on day 2 after oocyte retrieval. , 2007, Human reproduction.

[13]  C. Simón,et al.  Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. , 2005, Human reproduction.

[14]  H. Tournaye,et al.  Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. , 2004, Fertility and sterility.

[15]  E. Kolibianakis,et al.  Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. , 2002, Fertility and sterility.

[16]  W. Ledger.  Patient scheduling for gonadotrophin-releasing hormone antagonist protocols , 2002, Human fertility.

[17]  F. Ubaldi,et al.  Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. , 1997, Fertility and sterility.

[18]  S. Campbell,et al.  A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization , 1992, Fertility and sterility.

[19]  J. Conaghan,et al.  Beneficial effects of a 24 h delay in human chorionic gonadotrophin administration during in-vitro fertilization treatment cycles. , 1991, Human reproduction.

[20]  J. Studd,et al.  Timed oocyte collection in an assisted conception programme using GnRH analogue. , 1989, Human reproduction.

[21]  J. Conaghan,et al.  DELAYED HUMAN CHORIONIC GONADOTROPIN ADMINISTRATION FOR IN-VITRO FERTILISATION , 1989, The Lancet.

[22]  N J Wald,et al.  MATERNAL SERUM-ALPHA-FETOPROTEIN MEASUREMENT IN ANTENATAL SCREENING FOR ANENCEPHALY AND SPINA BIFIDA IN EARLY PREGNANCY Report of U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects , 1977, The Lancet.

[23]  J. García-Velasco,et al.  To pill or not to pill in GnRH antagonist cycles: that is the question! , 2015, Reproductive biomedicine online.

[24]  C. Farquhar,et al.  Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques. , 2010, The Cochrane database of systematic reviews.

[25]  E. Greenblatt,et al.  In vitro fertilization programmed for weekday-only oocyte harvest: Analysis of outcome based on actual retrieval day , 2007, Journal of Assisted Reproduction and Genetics.